11 patents
Utility
Biomarkers for assessing breast cancer
8 Nov 22
The present invention relates to a metabolic biomarker set for use in assessing breast cancer in a mammalian subject.
Andre Lopes Carvalho, Rene Aloisio Da Costa Vieira, Ismael Dale Cotrim Guerreiro Da Silva, Edson Guimaraes Lo Turco, Therese Koal
Filed: 9 Mar 21
Utility
Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
3 Feb 22
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 19 Oct 21
Utility
Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
3 Feb 22
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 19 Oct 21
Utility
Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
23 Nov 21
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 14 Jun 19
Utility
Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
23 Nov 21
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 16 Dec 19
Utility
Biomarkers for Assessing Breast Cancer
24 Jun 21
The present invention relates to a metabolic biomarker set for use in assessing breast cancer in a mammalian subject.
Andre Lopes Carvalho, Rene Aloisio Da Costa Vieira, Ismael Dale Cotrim Guerreiro Da Silva, Edson Guimaraes Lo Turco, Therese Koal
Filed: 9 Mar 21
Utility
Biomarkers for assessing breast cancer
30 Mar 21
A metabolic biomarker set for use in assessing, screening, and/or diagnosing breast cancer in a mammalian subject includes at least (a) one amino acid selected from glutamine, glutamate and serine, and one lipid, or (b) glutamine and glutamate.
Andre Lopes Carvalho, Rene Aloisio Da Costa Vieira, Ismael Dale Cotrim Guerreiro Da Silva, Edson Guimaraes Lo Turco, Therese Koal
Filed: 10 Sep 15
Utility
Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
6 Jan 21
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 7 Mar 20
Utility
Metabolic Signatures Associated with Diagnosis, Disease Progression, and Immunological Response to Treatment of Patients with COVID-19
9 Dec 20
A system and method for using new biomarkers to assess individual diseases, including, but not limited to, a patient's prognosis before and/or after being diagnosed with the disease.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 5 Jul 20
Utility
Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
24 Jun 20
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 15 Dec 19
Utility
Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
18 Dec 19
A system and method for using new biomarkers to assess individual diseases is provided.
Robert Nagourney, Ismael Silva, Paulo D'Amora
Filed: 13 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first